
FDA Guidance on Discontinuance or Interruption Notification: Specific Aspects
The article highlights the aspects related to the definition of shortage and the steps the authority takes to mitigate the associated risks.
The article highlights the aspects related to the definition of shortage and the steps the authority takes to mitigate the associated risks.
The new article describes in detail the approach to be followed when applying for registration and marketing approval for Class A and B medical devices.
The new article describes the matters related to periodic evaluations the authority intends to conduct to ensure compliance with the applicable regulatory regiments.
The new article highlights the aspects related to the content and format of an application for initial recognition and re-recognition as a third-party 510k review organisation.
The new article describes in detail the applicable classification approach and highlights the key considerations associated thereto.